Dr. Nicholas Reder is a board certified and award winning pathologist and the CEO and founder of Alpenglow Biosciences, Inc., a 3D spatial biology company. He received a B.S. in biochemistry from the University of Michigan, an M.P.H. in epidemiology from Emory University, and an M.D. from Loyola University Chicago before receiving his pathology training at University of Washington, where he completed an anatomic pathology residency followed by a genitourinary pathology fellowship. While in residency, Dr. Reder won the Castleman Award, the highest honor for a pathologist under the age of 40. After spinning out the core technology from University of Washington, Alpenglow created a complete endtoend solution to accelerate drug development including the 3D imager, 3D image processing, and 3D analysis to accelerate drug development and enhance clinical diagnostics
3D spatial biology
3D spatial biology accelerates drug development and improves clinical diagnostics. This talk will provide an introduction to the technology underpinning 3D spatial biology and describe applications in drug development and clinical research where 3D data provides significant advantages over slidebased 2D data.
Alpenglow Biosciences uses AI-powered 3D spatial biology to add a new dimension to pathology, accelerating drug development and enhance clinical diagnostics.